Abstract
Angiogenesis is essential for normal tissue and even more so for solid malignancies. At present, inhibition of tumor angiogenesis is a major focus of anticancer drug development. Bevacizumab, a humanized antibody against VEGF, was the first antiangiogenic agent to be approved for advanced non-small cell lung cancer, breast cancer and colorectal cancer. The most commonly observed adverse events are hypertension, proteinuria, bleeding and thrombosis. Sunitinib, a small molecule blocking intracellular VEGF, KIT, Flt3 and PDGF receptors, which regulate angiogenesis and cell growth, is approved for the treatment of advanced renal cell cancer (RCC) and malignant gastrointestinal stromal tumor. The most frequent adverse events include hand-foot syndrome, stomatitis, diarrhea, fatigue, hypothyroidism and hypertension. Sorafenib, an oral multikinase inhibitor, is approved for the second-line treatment of advanced RCC and upfront treatment of advanced hepatocellular carcinoma. Most common adverse events with sorafenib are dermatologic (hand-foot skin reaction, rash, desquamation), fatigue, diarrhea, nausea, hypothyroidism and hypertension. More recently, cardiovascular toxicity has increasingly been recognized as a potential adverse even...Continue Reading
Citations
Sep 20, 2011·International Journal of Clinical Oncology·Yoshinori HoshinoYuko Kitagawa
Nov 26, 2011·Targeted Oncology·Gaetan des GuetzJean-François Morère
Sep 7, 2011·Cardiovascular Toxicology·Francesca BonuraNatale D'Alessandro
Oct 8, 2013·Drugs & Aging·D GermanoB Daniele
Sep 14, 2013·The Lancet Oncology·David CunninghamUNKNOWN AVEX study investigators
Feb 23, 2013·Journal of Cardiovascular Pharmacology·Pierre Maison-BlancheEmmanuelle Magherini
Dec 3, 2011·The Oncologist·Hilda WongThomas Yau
Aug 28, 2012·The Oncologist·José A Serra-RexachMiguel Martín
Apr 8, 2014·EMBO Molecular Medicine·Iacovos P MichaelAndras Nagy
Jan 10, 2012·Medical Physics·Wilfred NgwaRoss I Berbeco
Aug 18, 2010·Cancer Metastasis Reviews·Elvira Gonzalez de Mejia, Vermont P Dia
Jan 31, 2012·Gastroenterology Research and Practice·Renato CannizzaroPaola Spessotto
Mar 31, 2012·Evidence-based Complementary and Alternative Medicine : ECAM·Saswati MahapatraKrishna Vanaja Donkena
Oct 10, 2014·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Isamu OkamotoKazuhiko Nakagawa
Jan 10, 2012·The American Journal of the Medical Sciences·Jessica M FleagleCarl E Freter
Nov 6, 2015·Cancer·Marina D KaymakcalanToni K Choueiri
Dec 31, 2015·Current Urology Reports·Tania González León, Maricela Morera Pérez
Jun 19, 2012·Cancer Treatment Reviews·Corey J LangerPieter E Postmus
Feb 7, 2012·Cancer Treatment Reviews·Ahmad AwadaLouis Chow
Mar 13, 2012·Revue des maladies respiratoires·C Clément-DuchêneY Martinet
Oct 4, 2011·Bioorganic & Medicinal Chemistry Letters·Hye-Eun ChoiKyung-Tae Lee
Mar 8, 2016·Oncogenesis·X YangD Zheng
Apr 2, 2016·Proceedings of the National Academy of Sciences of the United States of America·Yin ZhangYihai Cao
May 28, 2013·Journal of Hepatology·Rita GolfieriUNKNOWN European Network on Radioembolization with Yttrium-90 Microspheres (ENRY) study collaborators
Mar 26, 2015·Future Oncology·Ahmed El Kaffas, Gregory J Czarnota
Dec 5, 2014·International Journal of Cancer. Journal International Du Cancer·Wang MaXiaolong Qi
Feb 28, 2014·The Korean Journal of Internal Medicine·Seon Ha BaekKwon-Wook Joo
Sep 12, 2014·International Journal of Nephrology·Hassan Izzedine
Dec 21, 2013·Critical Reviews in Oncology/hematology·Rim S IshakFadi S Farhat
Mar 3, 2012·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Sandra FeldtMartin Schulz
Feb 18, 2015·PloS One·Hao HuZhengqiang Yang
May 10, 2012·Technology in Cancer Research & Treatment·Ahmed El KaffasGregory J Czarnota
Sep 13, 2020·The Oncologist·Tetsuji TerazawaTaroh Satoh
Feb 16, 2017·Drugs & Aging·Gonzalo Tapia RicoTimothy J Price
Aug 12, 2018·JAMA Oncology·Baohui HanYan Sun
Jun 27, 2019·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·J FeliuM J Molina-Garrido
Sep 9, 2011·Molecular Cancer Research : MCR·Alisson L MatsuoLuiz R Travassos
Sep 15, 2011·Bulletin du cancer·Florence Joly
Apr 4, 2021·Biomedicines·Miguel Á TejadaRaúl Gómez
Jul 8, 2021·Journal of Leukocyte Biology·Hui YuLin Xiang